+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

Rexulti (brexpiprazole) Drug Overview 2019 - Product Thumbnail Image

Rexulti (brexpiprazole) Drug Overview 2019

  • Report
  • March 2019
  • 33 Pages
  • Global
Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Fetzima (levomilnacipran; Allergan) Drug Overview 2019 - Product Thumbnail Image

Fetzima (levomilnacipran; Allergan) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Drug Overview: Risperdal Consta - Product Thumbnail Image

Drug Overview: Risperdal Consta

  • Report
  • April 2018
  • 26 Pages
  • Global
From
Drug Overview: Lonasen - Product Thumbnail Image

Drug Overview: Lonasen

  • Report
  • March 2018
  • 17 Pages
  • Global
From
Drug Overview: Invega Sustenna/Invega Trinza - Product Thumbnail Image

Drug Overview: Invega Sustenna/Invega Trinza

  • Report
  • March 2018
  • 20 Pages
  • Global
From
From
Mental Illness Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Mental Illness Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 92 Pages
  • China
From
Research Report on China's Venlafaxine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Venlafaxine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Research Report on China's Escitalopram Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Escitalopram Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
From
From
From
From
From
United States SAGE-217 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States SAGE-217 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • United States
From
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more